PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
16-Jan-2024 TrakCel launches Consultancy Services to share extensive cell and gene therapy process development expertise TrakCel
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
16-Jan-2024 Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference Theriva Biologics, Inc
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
12-Jan-2024 Avery Dennison at Pharmapack 2024: showcasing the latest technologies that boost patient safety Avery Dennison
10-Jan-2024 Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma Ariceum Therapeutics
10-Jan-2024 AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union AbbVie
10-Jan-2024 Human Microbiome Market Set to Reach USD 6.5 Billion by 2032 Global Market Insights, Inc.
10-Jan-2024 Avance Clinical: Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Avance Clinical
09-Jan-2024 Ablatus Creators of Luna launches crowfunding campaign inviting community to join the fight against uterine fibroids  Ablatus Creators of Luna
09-Jan-2024 AT-HOME APP LAUNCHES AS NHS REVEALS ALMOST 2M HOSPITALISED DUE TO UTI Newfoundland
09-Jan-2024 Nutrigene Launches Personalised Development Program to Intersect Genetics and Learning through DNA Nutrigene Modern Sciences Sdn. Bhd
09-Jan-2024 AMLo Biosciences publish pivotal data for diagnostic biomarker technology AMBLor® in identifying melanomas at low risk of metastasis AMLo Biosciences
08-Jan-2024 Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals Bayer and RTW Investments, LP (“RTW”)
08-Jan-2024 Cell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sector The Cell and Gene Therapy Catapult
08-Jan-2024 Type 2 Diabetes Market: Analysis Of Epidemiology, Industry Trends, Size, Share, And Future Forecast (2023-2033) IMARC Group
05-Jan-2024 LAUSANNE, Switzerland, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it received a notice from the New York Stock Exchange (NYSE) on January 2, 2024 that the Company has regained compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE Listed Company Manual and, as a result, will be removed from the NYSE’s noncompliant issuers list. The Company previously received a notice from the NYSE that it was not in comp ADC Therapeutics
04-Jan-2024 The England areas with the longest distance to GP services Journo Research
04-Jan-2024 Single Cell RNA Sequencing Kits Market: Trends, Innovations, and Growth Opportunities Stringent Datalytics
03-Jan-2024 OncoZenge submits application for PRIME status in the EU OncoZenge